Betting on biogenerics

descriptionPublicationkeyboard_double_arrow_right Article 01 Feb 2001 English Publisher:Springer Science and Business Media LLCJournal:Nature Biotechnology, volume 19, pages 117-120 (issn: 1087-0156, eissn: 1546-1696,

Copyright policy )

Authors: A, Dove;

doi: 10.1038/84365

pmid: 11175723

Betting on biogenerics

- Summary
- Subjects
- Metrics

Abstract

With patents on several blockbuster therapeutic proteins soon to expire and several companies pondering whether to manufacture their own versions of these medicines, can a commercially viable business be based on biogenerics?

Keywords

Drug Industry, United States Food and Drug Administration, Agriculture, Recombinant Proteins, United States, Animals, Genetically Modified, Patents as Topic, Animals, Drugs, Generic, Humans, Biotechnology

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	13
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average